Fixed combination of oral NEPA (netupitant‐palonosetron) for the prevention of acute and delayed chemotherapy‐induced nausea and vomiting in patients receiving multiple cycles of chemotherapy: efficacy data from 2 randomized, double‐blind phase III studies
The efficacy of oral NEPA (netupitant‐palonosetron 300/0.50 mg) was evaluated from two randomized phase III studies in patients receiving HEC, AC, or MEC over multiple chemotherapy cycles. Oral NEPA ...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
09 April 2019
|
| In: |
Cancer medicine
Year: 2019, Volume: 8, Issue: 5, Pages: 2064-2073 |
| ISSN: | 2045-7634 |
| DOI: | 10.1002/cam4.2091 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1002/cam4.2091 Verlag: https://onlinelibrary.wiley.com/doi/10.1002/cam4.2091 
|
| Author Notes: | Lee Schwartzberg, Meinolf Karthaus, Giorgia Rossi, Giada Rizzi, Maria E. Borroni, Hope S. Rugo, Karin Jordan, Vincent Hansen |
| Summary: | The efficacy of oral NEPA (netupitant‐palonosetron 300/0.50 mg) was evaluated from two randomized phase III studies in patients receiving HEC, AC, or MEC over multiple chemotherapy cycles. Oral NEPA ... |
|---|---|
| Item Description: | Gesehen am 25.11.2019 |
| Physical Description: | Online Resource |
| ISSN: | 2045-7634 |
| DOI: | 10.1002/cam4.2091 |